LCT Medical
LCT Medical · 1182 Stuyvesant Avenue · Irvington, NJ 07111
4.8· 600 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
About this practice
LCT Medical is an internal medicine practice in Irvington, New Jersey. Its website describes preventive care, annual and DOT physicals, and physician-supervised weight management that usually focuses on lifestyle changes, and it names Chidi Anukwuem, MD, and Miriam Joseph, NP. The site places Dr. Anukwuem in both Irvington and Old Bridge. On Google it holds a 4.8-star rating across 600 reviews dating back to 2019, with 48 in the past year; reviewers most often mention the staff, the team's knowledge and feeling cared for.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-26. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.8 across 600 Google reviews. Of the 100 reviews we analyzed, 98 (98%) are positive (4–5★) and 1 (1%) are negative (1–2★).
What patients like
- Friendly, helpful staff34 reviews
- Feeling listened to16 reviews
- Knowledgeable, professional providers14 reviews
- Clean, comfortable office3 reviews
Common complaints
Very few complaints — only 1 negative review, with no recurring theme.
Most recent Google reviews
john k.★★★★★2026-09-26U guys never called I had telle medical appt on Friday. Nobody contacted me
kidrapvlogs q.★★★★★2026-08-05I give LCT Medical an A+ for the care and time spent listening to my medical situation. Very friendly place. Orin O.
Minnie H.★★★★★2026-08-01Very professional first time there answer all my question. Made me fill Very comfortable yes I recommend my family and friends. Thank you
Courtney M.★★★★★2026-07-28Had a great experience with my mother in law for her first time visit. Wasn’t a long wait and the NP was very patient and took care of her well.
Lewis G.★★★★★2026-07-23The doctor and the staff are very polite and friendly and are there to help you with your needs at a timely fashion I give this clinic a 5 star rating.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs